Back to Stakeholders
Care Delivery & Psychedelic FacilitationClinical Care Delivery OrganizationsHealth Systems & Hospitals
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchUniversities and Colleges without Dedicated Psychedelic Research Groups
Care Delivery & Psychedelic FacilitationClinical Care Delivery Organizations
Care Delivery & Psychedelic Facilitation
Research, Drug Development & Manufacturing

Peking University First Hospital

China
5 Trials

Leading academic hospital in Beijing affiliated with Peking University. Has conducted ketamine clinical trials including a randomized study of low-dose ketamine for perinatal depression, contributing to China's growing body of research on rapid-acting antidepressant therapies.

Academic Research

0 papers

Published Papers

0

Trial Involvement

5

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Other
HQ
China
Website
Visit

Sponsored Trials

5
Unknown statusNA

Esketamine Adjuvant Therapy for Patients With Chronic Visceral Pain Comorbid Major Depressive Disorder

Start Date
Compounds
Placebo, Esketamine
Active not recruitingIV

Effect of Low-dose Esketamine on Maternal Depression at 2 Years After Childbirth

Start Date
Compounds
Esketamine, Placebo
CompletedNA

Low-dose S-Ketamine and Postpartum Depression in Parturients With Prenatal Depression

Start Date
Compounds
Esketamine, Placebo
CompletedNA

Low-dose S-ketamine in Women With Prenatal Depression

Start Date
Compounds
Ketamine, Placebo
CompletedIV

Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression

Start Date
Compounds
Ketamine, Placebo